explore -WSS

explore

author：entertainment 2025-09-07 06:44:32 - browse：25

Grail spent more than $1 million last quarter lobbying Congress, underscoring the urgency of the company’s bid to secure Medicare coverage for its pricey blood-based cancer screening test that has been on the market for over a year but is not widely used.

A recently posted lobbying report indicates that, during the fourth quarter of last year, the biotech spent $1.07 million on “issues related to oncology and multi-cancer early detection,” including House and Senate bills that would allow Medicare to cover multi-cancer screening tests. That figure has been rising; during the fourth quarter of 2021, the company spent $470,000 on lobbying. That’s far more than cancer and genetic testing biotechs such as Guardant Health, Myriad Genetics, and Tempus, which spent anywhere from $90,000 to nearly $300,000 on lobbying last quarter.

The growing investment in lobbying elected officials comes at a time when Grail is looking to make its test, Galleri, available to a broader swath of the population. The test, launched in 2021, can detect early signs of more than 50 cancers among people who don’t have symptoms. That’s because cancer cells release bits of DNA into the bloodstream, and Galleri spots telltale modifications to this DNA.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Flu vaccine reformulation won't be easy, manufacturers warn

WSS

There's an unseen cost to disruptive road

FDA approves first blood sugar monitor without finger pricks

How a key Senate committee is planning to regulate PBMs

Men with early prostate cancer can safely opt out of treatment

High breast density mammograms need follow

Mass General, Mayo Clinic look to monetize custom

knowledge

explore

focus

Cancer drug shortages should be causing more outrage

TikTok, Instagram influencers need more rules for drug ads

Supreme Court strikes down use of affirmative action

The response to Covid

Hollywood unions extend contract negotiations for actors

Inside the culture of fear in the White House science office of Eric Lander

Medical records are filled with copy

Transgender women dream of pregnancy via uterus transplants

Novavax promises a turnaround & Lilly roils the obesity market

Flu vaccine reformulation won't be easy, manufacturers warn

hotspot

What Henrietta Lacks's story taught me about my role as a doctor

TikTok, Instagram influencers need more rules for drug ads

There's an unseen cost to disruptive road

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

Maisha Meds is a PBM, but don't call it that

Statins reduce cardiovascular risk in people living with HIV

hotspot

hotspot

leisure time

explore